Skip to main content
Equibles

Helen M. Boudreau

Board Member

Shattuck Labs, Inc. (STTK)

Board Member

Tvardi Therapeutics, Inc. (TVRD)

Board Member

Rallybio Corp (RLYB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Shattuck Labs, Inc. publishes a filing, an earnings call transcript or a press release.

Get STTK alerts

About Helen M. Boudreau

Helen M. Boudreau is recorded as Board Member at Shattuck Labs, Inc. (STTK), Board Member at Tvardi Therapeutics, Inc. (TVRD) since August 2, 2023 and Board Member at Rallybio Corp (RLYB) since January 1, 2020. The newest filing on record that lists Helen M. Boudreau as Board Member at Shattuck Labs, Inc. (STTK) is dated April 8, 2026. The newest filing on record that lists Helen M. Boudreau as Board Member at Rallybio Corp (RLYB) is dated April 7, 2025. Rallybio Corp reported in an 8-K filed November 4, 2026 that Helen M. Boudreau was appointed Class II directors, effective November 4, 2026. Shattuck Labs, Inc. reported in an 8-K filed June 2, 2026 that Helen M. Boudreau was appointed Class III Director Nominee, effective May 28, 2026. Tvardi Therapeutics, Inc. reported in an 8-K filed April 15, 2025 that Helen M. Boudreau resigned as director, effective April 15, 2025. Equibles holds 4 filed executive changes naming Helen M. Boudreau; each is listed under recent activity with its source filing. Rallybio Corp is classified in the Biotechnology industry within the Healthcare sector. Shattuck Labs, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rallybio Corp includes Athena Countouriotis, M.D. (CEO), Stephen Uden (CEO, COO and Board Member), Stephen Uden, M.D. (CEO and Board Member) and 7 others.

“The stockholders of record of the Company voted to elect Stephen Uden, Helen M. Boudreau, Lucian Iancovici, and Christine A. Nash as Class II directors, each for a three-year term and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Rallybio Corp Form 8-K, filed November 4, 2026 · Read the filing
“At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received the plurality of votes cast on Proposal 4 and the other proposals voted on were approved.”
Shattuck Labs, Inc. Form 8-K, filed June 2, 2026 · Read the filing

Affiliation history

Company network

Rallybio Corp

RLYB

Current role

Biotechnology · Healthcare

Board Member

2020-01-01–present

Leadership on record at Rallybio Corp

Leadership on record at Shattuck Labs, Inc.

Leadership on record at Tvardi Therapeutics, Inc.

Recent activity